Product
Aerosolized Ad5-nCoV
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults Aged 18 Years or Above: a Multicenter, Parallel Groups, Partially Randomized, Open-label, Blank-controlled Adaptive Platform TrialStatus: Not yet recruiting, Estimated PCD: 2024-05-18